Product
Interferon α2b
1 clinical trial
2 indications
Indication
COVID-19Indication
ChildhoodClinical trial
Inhaled Interferon α2b Treatment in Mild-to-moderate COVID-19 Infected ChildrenStatus: Terminated, Estimated PCD: 2023-01-01
1 clinical trial
2 indications